Toll Free: 1-888-928-9744
Published: Jan, 2018 | Pages:
105 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Brucellosis Vaccines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: The West Southwest The Middle Atlantic New England The South The Midwest with sales (volume), revenue (value), market share and growth rate of Brucellosis Vaccines in these regions, from 2013 to 2025 (forecast). United States Brucellosis Vaccines market competition by top manufacturers/players, with Brucellosis Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Jinyu Colorado Serum Boehringer Ingelheim Biogenesis-Bago Vetal Company CZ Veterinaria SYVA Laboratorios Indian Immunologicals Qilu Tecnovax Hester Biosciences Zoetis Onderstepoort Biological Instituto Rosenbusch Ceva Sante Animale Calier & Biologicos Laverlam Biovet On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into S19 Vaccine RB51 Vaccine Strain Other On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Cattle Sheep Other If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents United States Brucellosis Vaccines Market Report 2018 1 Brucellosis Vaccines Overview 1.1 Product Overview and Scope of Brucellosis Vaccines 1.2 Classification of Brucellosis Vaccines by Product Category 1.2.1 United States Brucellosis Vaccines Market Size (Sales Volume) Comparison by Type (2013-2025) 1.2.2 United States Brucellosis Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2017 1.2.3 S19 Vaccine 1.2.4 RB51 Vaccine Strain 1.2.5 Other 1.3 United States Brucellosis Vaccines Market by Application/End Users 1.3.1 United States Brucellosis Vaccines Market Size (Consumption) and Market Share Comparison by Application (2013-2025) 1.3.2 Cattle 1.3.3 Sheep 1.3.4 Other 1.4 United States Brucellosis Vaccines Market by Region 1.4.1 United States Brucellosis Vaccines Market Size (Value) Comparison by Region (2013-2025) 1.4.2 The West Brucellosis Vaccines Status and Prospect (2013-2025) 1.4.3 Southwest Brucellosis Vaccines Status and Prospect (2013-2025) 1.4.4 The Middle Atlantic Brucellosis Vaccines Status and Prospect (2013-2025) 1.4.5 New England Brucellosis Vaccines Status and Prospect (2013-2025) 1.4.6 The South Brucellosis Vaccines Status and Prospect (2013-2025) 1.4.7 The Midwest Brucellosis Vaccines Status and Prospect (2013-2025) 1.5 United States Market Size (Value and Volume) of Brucellosis Vaccines (2013-2025) 1.5.1 United States Brucellosis Vaccines Sales and Growth Rate (2013-2025) 1.5.2 United States Brucellosis Vaccines Revenue and Growth Rate (2013-2025) 2 United States Brucellosis Vaccines Market Competition by Players/Suppliers 2.1 United States Brucellosis Vaccines Sales and Market Share of Key Players/Suppliers (2013-2018) 2.2 United States Brucellosis Vaccines Revenue and Share by Players/Suppliers (2013-2018) 2.3 United States Brucellosis Vaccines Average Price by Players/Suppliers (2013-2018) 2.4 United States Brucellosis Vaccines Market Competitive Situation and Trends 2.4.1 United States Brucellosis Vaccines Market Concentration Rate 2.4.2 United States Brucellosis Vaccines Market Share of Top 3 and Top 5 Players/Suppliers 2.4.3 Mergers & Acquisitions, Expansion in United States Market 2.5 United States Players/Suppliers Brucellosis Vaccines Manufacturing Base Distribution, Sales Area, Product Type 3 United States Brucellosis Vaccines Sales (Volume) and Revenue (Value) by Region (2013-2018) 3.1 United States Brucellosis Vaccines Sales and Market Share by Region (2013-2018) 3.2 United States Brucellosis Vaccines Revenue and Market Share by Region (2013-2018) 3.3 United States Brucellosis Vaccines Price by Region (2013-2018) 4 United States Brucellosis Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018) 4.1 United States Brucellosis Vaccines Sales and Market Share by Type (Product Category) (2013-2018) 4.2 United States Brucellosis Vaccines Revenue and Market Share by Type (2013-2018) 4.3 United States Brucellosis Vaccines Price by Type (2013-2018) 4.4 United States Brucellosis Vaccines Sales Growth Rate by Type (2013-2018) 5 United States Brucellosis Vaccines Sales (Volume) by Application (2013-2018) 5.1 United States Brucellosis Vaccines Sales and Market Share by Application (2013-2018) 5.2 United States Brucellosis Vaccines Sales Growth Rate by Application (2013-2018) 5.3 Market Drivers and Opportunities 6 United States Brucellosis Vaccines Players/Suppliers Profiles and Sales Data 6.1 Jinyu 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 Brucellosis Vaccines Product Category, Application and Specification 6.1.2.1 Product A 6.1.2.2 Product B 6.1.3 Jinyu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.1.4 Main Business/Business Overview 6.2 Colorado Serum 6.2.2 Brucellosis Vaccines Product Category, Application and Specification 6.2.2.1 Product A 6.2.2.2 Product B 6.2.3 Colorado Serum Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.2.4 Main Business/Business Overview 6.3 Boehringer Ingelheim 6.3.2 Brucellosis Vaccines Product Category, Application and Specification 6.3.2.1 Product A 6.3.2.2 Product B 6.3.3 Boehringer Ingelheim Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.3.4 Main Business/Business Overview 6.4 Biogenesis-Bago 6.4.2 Brucellosis Vaccines Product Category, Application and Specification 6.4.2.1 Product A 6.4.2.2 Product B 6.4.3 Biogenesis-Bago Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.4.4 Main Business/Business Overview 6.5 Vetal Company 6.5.2 Brucellosis Vaccines Product Category, Application and Specification 6.5.2.1 Product A 6.5.2.2 Product B 6.5.3 Vetal Company Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.5.4 Main Business/Business Overview 6.6 CZ Veterinaria 6.6.2 Brucellosis Vaccines Product Category, Application and Specification 6.6.2.1 Product A 6.6.2.2 Product B 6.6.3 CZ Veterinaria Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.6.4 Main Business/Business Overview 6.7 SYVA Laboratorios 6.7.2 Brucellosis Vaccines Product Category, Application and Specification 6.7.2.1 Product A 6.7.2.2 Product B 6.7.3 SYVA Laboratorios Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.7.4 Main Business/Business Overview 6.8 Indian Immunologicals 6.8.2 Brucellosis Vaccines Product Category, Application and Specification 6.8.2.1 Product A 6.8.2.2 Product B 6.8.3 Indian Immunologicals Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.8.4 Main Business/Business Overview 6.9 Qilu 6.9.2 Brucellosis Vaccines Product Category, Application and Specification 6.9.2.1 Product A 6.9.2.2 Product B 6.9.3 Qilu Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.9.4 Main Business/Business Overview 6.10 Tecnovax 6.10.2 Brucellosis Vaccines Product Category, Application and Specification 6.10.2.1 Product A 6.10.2.2 Product B 6.10.3 Tecnovax Brucellosis Vaccines Sales, Revenue, Price and Gross Margin (2013-2018) 6.10.4 Main Business/Business Overview 6.11 Hester Biosciences 6.12 Zoetis 6.13 Onderstepoort Biological 6.14 Instituto Rosenbusch 6.15 Ceva Sante Animale 6.16 Calier & Biologicos Laverlam 6.17 Biovet 7 Brucellosis Vaccines Manufacturing Cost Analysis 7.1 Brucellosis Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of Brucellosis Vaccines 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 Brucellosis Vaccines Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of Brucellosis Vaccines Major Manufacturers in 2017 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States Brucellosis Vaccines Market Size (Value and Volume) Forecast (2018-2025) 11.1 United States Brucellosis Vaccines Sales Volume, Revenue Forecast (2018-2025) 11.2 United States Brucellosis Vaccines Sales Volume Forecast by Type (2018-2025) 11.3 United States Brucellosis Vaccines Sales Volume Forecast by Application (2018-2025) 11.4 United States Brucellosis Vaccines Sales Volume Forecast by Region (2018-2025) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer
List of Tables and Figures Figure Product Picture of Brucellosis Vaccines Figure United States Brucellosis Vaccines Market Size (M Doses) by Type (2013-2025) Figure United States Brucellosis Vaccines Sales Volume Market Share by Type (Product Category) in 2017 Figure S19 Vaccine Product Picture Figure RB51 Vaccine Strain Product Picture Figure Other Product Picture Figure United States Brucellosis Vaccines Market Size (M Doses) by Application (2013-2025) Figure United States Sales Market Share of Brucellosis Vaccines by Application in 2017 Figure Cattle Examples Table Key Downstream Customer in Cattle Figure Sheep Examples Table Key Downstream Customer in Sheep Figure Other Examples Table Key Downstream Customer in Other Figure United States Brucellosis Vaccines Market Size (Million USD) by Region (2013-2025) Figure The West Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure Southwest Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure The Middle Atlantic Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure New England Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure The South of US Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure The Midwest Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Brucellosis Vaccines Sales (M Doses) and Growth Rate (2013-2025) Figure United States Brucellosis Vaccines Revenue (Million USD) and Growth Rate (2013-2025) Figure United States Brucellosis Vaccines Market Major Players Product Sales Volume (M Doses) (2013-2018) Table United States Brucellosis Vaccines Sales (M Doses) of Key Players/Suppliers (2013-2018) Table United States Brucellosis Vaccines Sales Share by Players/Suppliers (2013-2018) Figure 2017 United States Brucellosis Vaccines Sales Share by Players/Suppliers Figure 2017 United States Brucellosis Vaccines Sales Share by Players/Suppliers Figure United States Brucellosis Vaccines Market Major Players Product Revenue (Million USD) (2013-2018) Table United States Brucellosis Vaccines Revenue (Million USD) by Players/Suppliers (2013-2018) Table United States Brucellosis Vaccines Revenue Share by Players/Suppliers (2013-2018) Figure 2017 United States Brucellosis Vaccines Revenue Share by Players/Suppliers Figure 2017 United States Brucellosis Vaccines Revenue Share by Players/Suppliers Table United States Market Brucellosis Vaccines Average Price (USD/K Doses) of Key Players/Suppliers (2013-2018) Figure United States Market Brucellosis Vaccines Average Price (USD/K Doses) of Key Players/Suppliers in 2017 Figure United States Brucellosis Vaccines Market Share of Top 3 Players/Suppliers Figure United States Brucellosis Vaccines Market Share of Top 5 Players/Suppliers Table United States Players/Suppliers Brucellosis Vaccines Manufacturing Base Distribution and Sales Area Table United States Players/Suppliers Brucellosis Vaccines Product Category Table United States Brucellosis Vaccines Sales (M Doses) by Region (2013-2018) Table United States Brucellosis Vaccines Sales Share by Region (2013-2018) Figure United States Brucellosis Vaccines Sales Share by Region (2013-2018) Figure United States Brucellosis Vaccines Sales Market Share by Region in 2017 Table United States Brucellosis Vaccines Revenue (Million USD) and Market Share by Region (2013-2018) Table United States Brucellosis Vaccines Revenue Share by Region (2013-2018) Figure United States Brucellosis Vaccines Revenue Market Share by Region (2013-2018) Figure United States Brucellosis Vaccines Revenue Market Share by Region in 2017 Table United States Brucellosis Vaccines Price (USD/K Doses) by Region (2013-2018) Table United States Brucellosis Vaccines Sales (M Doses) by Type (2013-2018) Table United States Brucellosis Vaccines Sales Share by Type (2013-2018) Figure United States Brucellosis Vaccines Sales Share by Type (2013-2018) Figure United States Brucellosis Vaccines Sales Market Share by Type in 2017 Table United States Brucellosis Vaccines Revenue (Million USD) and Market Share by Type (2013-2018) Table United States Brucellosis Vaccines Revenue Share by Type (2013-2018) Figure Revenue Market Share of Brucellosis Vaccines by Type (2013-2018) Figure Revenue Market Share of Brucellosis Vaccines by Type in 2017 Table United States Brucellosis Vaccines Price (USD/K Doses) by Types (2013-2018) Figure United States Brucellosis Vaccines Sales Growth Rate by Type (2013-2018) Table United States Brucellosis Vaccines Sales (M Doses) by Application (2013-2018) Table United States Brucellosis Vaccines Sales Market Share by Application (2013-2018) Figure United States Brucellosis Vaccines Sales Market Share by Application (2013-2018) Figure United States Brucellosis Vaccines Sales Market Share by Application in 2017 Table United States Brucellosis Vaccines Sales Growth Rate by Application (2013-2018) Figure United States Brucellosis Vaccines Sales Growth Rate by Application (2013-2018) Table Jinyu Basic Information List Table Jinyu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Jinyu Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Jinyu Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Jinyu Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Colorado Serum Basic Information List Table Colorado Serum Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Colorado Serum Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Colorado Serum Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Colorado Serum Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Boehringer Ingelheim Basic Information List Table Boehringer Ingelheim Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Boehringer Ingelheim Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Boehringer Ingelheim Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Boehringer Ingelheim Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Biogenesis-Bago Basic Information List Table Biogenesis-Bago Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Biogenesis-Bago Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Biogenesis-Bago Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Biogenesis-Bago Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Vetal Company Basic Information List Table Vetal Company Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Vetal Company Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Vetal Company Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Vetal Company Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table CZ Veterinaria Basic Information List Table CZ Veterinaria Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure CZ Veterinaria Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure CZ Veterinaria Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure CZ Veterinaria Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table SYVA Laboratorios Basic Information List Table SYVA Laboratorios Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure SYVA Laboratorios Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure SYVA Laboratorios Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure SYVA Laboratorios Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Indian Immunologicals Basic Information List Table Indian Immunologicals Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Indian Immunologicals Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Indian Immunologicals Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Indian Immunologicals Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Qilu Basic Information List Table Qilu Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Qilu Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Qilu Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Qilu Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Tecnovax Basic Information List Table Tecnovax Brucellosis Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2013-2018) Figure Tecnovax Brucellosis Vaccines Sales Growth Rate (2013-2018) Figure Tecnovax Brucellosis Vaccines Sales Market Share in United States (2013-2018) Figure Tecnovax Brucellosis Vaccines Revenue Market Share in United States (2013-2018) Table Hester Biosciences Basic Information List Table Zoetis Basic Information List Table Onderstepoort Biological Basic Information List Table Instituto Rosenbusch Basic Information List Table Ceva Sante Animale Basic Information List Table Calier & Biologicos Laverlam Basic Information List Table Biovet Basic Information List Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Brucellosis Vaccines Figure Manufacturing Process Analysis of Brucellosis Vaccines Figure Brucellosis Vaccines Industrial Chain Analysis Table Raw Materials Sources of Brucellosis Vaccines Major Players/Suppliers in 2017 Table Major Buyers of Brucellosis Vaccines Table Distributors/Traders List Figure United States Brucellosis Vaccines Sales Volume (M Doses) and Growth Rate Forecast (2018-2025) Figure United States Brucellosis Vaccines Revenue (Million USD) and Growth Rate Forecast (2018-2025) Figure United States Brucellosis Vaccines Price (USD/K Doses) Trend Forecast (2018-2025) Table United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Type (2018-2025) Figure United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Type (2018-2025) Figure United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Type in 2025 Table United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Application (2018-2025) Figure United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Application (2018-2025) Figure United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Application in 2025 Table United States Brucellosis Vaccines Sales Volume (M Doses) Forecast by Region (2018-2025) Table United States Brucellosis Vaccines Sales Volume Share Forecast by Region (2018-2025) Figure United States Brucellosis Vaccines Sales Volume Share Forecast by Region (2018-2025) Figure United States Brucellosis Vaccines Sales Volume Share Forecast by Region in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.